These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24757229)

  • 1. Frequency of morning ketosis after overnight insulin suspension using an automated nocturnal predictive low glucose suspend system.
    Beck RW; Raghinaru D; Wadwa RP; Chase HP; Maahs DM; Buckingham BA;
    Diabetes Care; 2014; 37(5):1224-9. PubMed ID: 24757229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketone production in children with type 1 diabetes, ages 4-14 years, with and without nocturnal insulin pump suspension.
    Wadwa RP; Chase HP; Raghinaru D; Buckingham BA; Hramiak I; Maahs DM; Messer L; Ly T; Aye T; Clinton P; Kollman C; Beck RW; Lum J;
    Pediatr Diabetes; 2017 Sep; 18(6):422-427. PubMed ID: 27402452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of nighttime 2-hour suspension of Basal insulin in pump-treated type 1 diabetes even in the absence of low glucose.
    Sherr JL; Palau Collazo M; Cengiz E; Michaud C; Carria L; Steffen AT; Weyman K; Zgorski M; Tichy E; Tamborlane WV; Weinzimer SA
    Diabetes Care; 2014; 37(3):773-9. PubMed ID: 24170766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes.
    Maahs DM; Calhoun P; Buckingham BA; Chase HP; Hramiak I; Lum J; Cameron F; Bequette BW; Aye T; Paul T; Slover R; Wadwa RP; Wilson DM; Kollman C; Beck RW;
    Diabetes Care; 2014 Jul; 37(7):1885-91. PubMed ID: 24804697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension.
    Buckingham B; Chase HP; Dassau E; Cobry E; Clinton P; Gage V; Caswell K; Wilkinson J; Cameron F; Lee H; Bequette BW; Doyle FJ
    Diabetes Care; 2010 May; 33(5):1013-7. PubMed ID: 20200307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemia.
    Buckingham BA; Cameron F; Calhoun P; Maahs DM; Wilson DM; Chase HP; Bequette BW; Lum J; Sibayan J; Beck RW; Kollman C
    Diabetes Technol Ther; 2013 Aug; 15(8):622-7. PubMed ID: 23883408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Hyperglycemia and Hypoglycemia Minimization: In-Home Evaluation of Safety, Feasibility, and Efficacy in Overnight Glucose Control in Type 1 Diabetes.
    Spaic T; Driscoll M; Raghinaru D; Buckingham BA; Wilson DM; Clinton P; Chase HP; Maahs DM; Forlenza GP; Jost E; Hramiak I; Paul T; Bequette BW; Cameron F; Beck RW; Kollman C; Lum JW; Ly TT;
    Diabetes Care; 2017 Mar; 40(3):359-366. PubMed ID: 28100606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Automated Insulin Suspension and Glucose Responses with the Predictive Low-Glucose Management System.
    Abraham MB; Smith GJ; Nicholas JA; Fairchild JM; King BR; Ambler GR; Cameron FJ; Davis EA; Jones TW;
    Diabetes Technol Ther; 2019 Jan; 21(1):28-34. PubMed ID: 30585769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial.
    Hovorka R; Elleri D; Thabit H; Allen JM; Leelarathna L; El-Khairi R; Kumareswaran K; Caldwell K; Calhoun P; Kollman C; Murphy HR; Acerini CL; Wilinska ME; Nodale M; Dunger DB
    Diabetes Care; 2014; 37(5):1204-11. PubMed ID: 24757227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of an Overnight Predictive Low-Glucose Suspend System in Relation to Hypoglycemia Risk Factors in Youth and Adults With Type 1 Diabetes.
    Calhoun PM; Buckingham BA; Maahs DM; Hramiak I; Wilson DM; Aye T; Clinton P; Chase P; Messer L; Kollman C; Beck RW; Lum J;
    J Diabetes Sci Technol; 2016 Nov; 10(6):1216-1221. PubMed ID: 27207890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of the predictive low glucose management system in the prevention of hypoglycaemia: protocol for randomised controlled home trial to evaluate the Suspend before low function.
    Abraham MB; Nicholas JA; Ly TT; Roby HC; Paramalingam N; Fairchild J; King BR; Ambler GR; Cameron F; Davis EA; Jones TW
    BMJ Open; 2016 Apr; 6(4):e011589. PubMed ID: 27084290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of glucose responses to automated insulin suspension with sensor-augmented pump therapy.
    Ly TT; Nicholas JA; Retterath A; Davis EA; Jones TW
    Diabetes Care; 2012 Jul; 35(7):1462-5. PubMed ID: 22584133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial.
    Nimri R; Muller I; Atlas E; Miller S; Fogel A; Bratina N; Kordonouri O; Battelino T; Danne T; Phillip M
    Diabetes Care; 2014 Nov; 37(11):3025-32. PubMed ID: 25078901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.
    Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW
    JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis.
    Buckingham BA; Raghinaru D; Cameron F; Bequette BW; Chase HP; Maahs DM; Slover R; Wadwa RP; Wilson DM; Ly T; Aye T; Hramiak I; Clarson C; Stein R; Gallego PH; Lum J; Sibayan J; Kollman C; Beck RW;
    Diabetes Care; 2015 Jul; 38(7):1197-204. PubMed ID: 26049549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multinight "bedside" closed-loop control for patients with type 1 diabetes.
    Brown SA; Kovatchev BP; Breton MD; Anderson SM; Keith-Hynes P; Patek SD; Jiang B; Ben Brahim N; Vereshchetin P; Bruttomesso D; Avogaro A; Del Favero S; Boscari F; Galasso S; Visentin R; Monaro M; Cobelli C
    Diabetes Technol Ther; 2015 Mar; 17(3):203-9. PubMed ID: 25594434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp.
    Ly TT; Breton MD; Keith-Hynes P; De Salvo D; Clinton P; Benassi K; Mize B; Chernavvsky D; Place J; Wilson DM; Kovatchev BP; Buckingham BA
    Diabetes Care; 2014 Aug; 37(8):2310-6. PubMed ID: 24879841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of Insulin-Induced Hypoglycemia in Type 1 Diabetes with Predictive Low Glucose Management System.
    Abraham MB; de Bock M; Paramalingam N; O'Grady MJ; Ly TT; George C; Roy A; Spital G; Karula S; Heels K; Gebert R; Fairchild JM; King BR; Ambler GR; Cameron F; Davis EA; Jones TW
    Diabetes Technol Ther; 2016 Jul; 18(7):436-43. PubMed ID: 27148807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes.
    Wood MA; Shulman DI; Forlenza GP; Bode BW; Pinhas-Hamiel O; Buckingham BA; Kaiserman KB; Liljenquist DR; Bailey TS; Shin J; Huang S; Chen X; Cordero TL; Lee SW; Kaufman FR
    Diabetes Technol Ther; 2018 Nov; 20(11):731-737. PubMed ID: 30299976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered Patterns of Early Metabolic Decompensation in Type 1 Diabetes During Treatment with a SGLT2 Inhibitor: An Insulin Pump Suspension Study.
    Patel NS; Van Name MA; Cengiz E; Carria LR; Weinzimer SA; Tamborlane WV; Sherr JL
    Diabetes Technol Ther; 2017 Nov; 19(11):618-622. PubMed ID: 29068709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.